Nauta JJ - Search Results

1

Database for serial magnetic resonance imaging in multiple sclerosis.

Barkhof F, Thompson AJ, Kappos L, Nauta JJ, Yousri T, Berry I, Scotti G, Appel B, Tofts PS, Miller DH. Barkhof F, et al. Among authors: nauta jj. Neuroradiology. 1993;35(5):362-6. doi: 10.1007/BF00588371. Neuroradiology. 1993. PMID: 8327113

2

Gadopentetate dimeglumine enhancement of multiple sclerosis lesions on long TR spin-echo images at 0.6 T.

Barkhof F, Valk J, Hommes OR, Scheltens P, Nauta JJ. Barkhof F, et al. Among authors: nauta jj. AJNR Am J Neuroradiol. 1992 Jul-Aug;13(4):1257-9. AJNR Am J Neuroradiol. 1992. PMID: 1636547 Free PMC article.

3

Limited duration of the effect of methylprednisolone on changes on MRI in multiple sclerosis.

Barkhof F, Tas MW, Frequin ST, Scheltens P, Hommes OR, Nauta JJ, Valk J. Barkhof F, et al. Among authors: nauta jj. Neuroradiology. 1994 Jul;36(5):382-7. doi: 10.1007/BF00612124. Neuroradiology. 1994. PMID: 7936181

4

Magnetic resonance imaging in monitoring the treatment of multiple sclerosis patients: statistical power of parallel-groups and crossover designs.

Nauta JJ, Thompson AJ, Barkhof F, Miller DH. Nauta JJ, et al. J Neurol Sci. 1994 Mar;122(1):6-14. doi: 10.1016/0022-510x(94)90045-0. J Neurol Sci. 1994. PMID: 8195804

5

Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity.

Barkhof F, Scheltens P, Frequin ST, Nauta JJ, Tas MW, Valk J, Hommes OR. Barkhof F, et al. Among authors: nauta jj. AJR Am J Roentgenol. 1992 Nov;159(5):1041-7. doi: 10.2214/ajr.159.5.1414773. AJR Am J Roentgenol. 1992. PMID: 1414773

6

White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity.

Scheltens P, Barkhof F, Valk J, Algra PR, van der Hoop RG, Nauta J, Wolters EC. Scheltens P, et al. Brain. 1992 Jun;115 ( Pt 3):735-48. doi: 10.1093/brain/115.3.735. Brain. 1992. PMID: 1628199

7

Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis.

Miller DH, Barkhof F, Nauta JJ. Miller DH, et al. Among authors: nauta jj. Brain. 1993 Oct;116 ( Pt 5):1077-94. doi: 10.1093/brain/116.5.1077. Brain. 1993. PMID: 8221048

8

A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging.

Scheltens P, Barkhof F, Leys D, Pruvo JP, Nauta JJ, Vermersch P, Steinling M, Valk J. Scheltens P, et al. Among authors: nauta jj. J Neurol Sci. 1993 Jan;114(1):7-12. doi: 10.1016/0022-510x(93)90041-v. J Neurol Sci. 1993. PMID: 8433101

9

Specific power calculations for magnetic resonance imaging (MRI) in monitoring active relapsing-remitting multiple sclerosis (MS): implications for phase II therapeutic trials.

Truyen L, Barkhof F, Tas M, Van Walderveen MA, Frequin ST, Hommes OR, Nauta JJ, Polman CH, Valk J. Truyen L, et al. Among authors: nauta jj. Mult Scler. 1997 Jan;2(6):283-90. doi: 10.1177/135245859700200604. Mult Scler. 1997. PMID: 9065919

10

Contrast enhanced magnetic resonance imaging of the brain using gadolinium-DTPA.

Valk J, de Slegte RG, Crezee FC, Hazenberg GJ, Thjaha SI, Nauta JJ. Valk J, et al. Among authors: nauta jj. Acta Radiol. 1987 Nov-Dec;28(6):659-65. Acta Radiol. 1987. PMID: 2962597 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters